Effects of Plasma from Acute-on-Chronic Liver Failure Patients on Immortalized Human Hepatocytes in vitro

被引:0
作者
Lv Guoliang [1 ]
Zhang Anye [1 ]
Zhao Lifu [1 ]
Pan Xiaoping [1 ]
Zhang Yimin [1 ]
Yu Chengbo [1 ]
Chen Yuemei [1 ]
Li Lanjuan [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Acute-on-chronic liver failure; Apoptosis; Bioartificial liver; Immortalized human hepatocytes; FULMINANT HEPATIC-FAILURE; OF-THE-ART; BIOARTIFICIAL LIVER; GROWTH-FACTOR; SERUM; TRANSPLANTATION; SUBSTANCES; THERAPY; CELLS;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The efficiency of bioartificial liver or cell transplantation for the treatment of liver failure may potentially be diminished by toxic agents accumulated in the patients' blood. We investigated the effects of plasma from patients with acute-on-chronic liver failure on the structure and function of immortalized human hepatocytes (HepLL) in vitro. Methodology: Plasma was pooled from 8 patients with acute or chronic liver failure. We utilized Transmission Electron Microscopy to observe the ultrastructure of HepLL cells and the activity of proliferation was examined by MTT assay. The percentage of apoptosis cells was measured through Annexin V-FITC apoptosis detection kit. The capacity for detoxification was analyzed using an ammonia elimination assay. Results: HepLL cells continue to proliferate, even when exposed to plasma derived from patients with 100% liver failure. No significant apoptosis was measured within 48h. The capacity for ammonia elimination was not statistically decreased until 36h incubation with liver failure plasma. Conclusions: Although the toxic effects of plasma from acute-on-chronic liver failure patients should not be ignored, HepLL cells can maintain their function, when exposed to AoCLF plasma, for at least 24h and could be used as a suitable cell source for a bioartificial liver support system.
引用
收藏
页码:1328 / 1333
页数:6
相关论文
共 26 条
[1]   Advances in bioartificial liver devices [J].
Allen, JW ;
Hassanein, T ;
Bhatia, SN .
HEPATOLOGY, 2001, 34 (03) :447-455
[2]   Assay to detect inhibitory substances in serum of patients with acute liver failure [J].
Anderson, C ;
Thabrew, MI ;
Hughes, RD .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1999, 22 (02) :113-117
[3]  
[Anonymous], 2006, ZHONGHUA GAN ZANG BI, V14, P643
[4]   High level benzodiazepine and ammonia clearance by flat membrane bioreactors with porcine liver cells [J].
Bader, A ;
De Bartolo, L ;
Haverich, A .
JOURNAL OF BIOTECHNOLOGY, 2000, 81 (2-3) :95-105
[5]  
BAI H, DIG DIS SCI, V55, P82
[6]   Bioartificial liver: Its pros and cons [J].
Chamuleau, RAFM ;
Poyck, PPC ;
van de Kerkhove, MP .
THERAPEUTIC APHERESIS AND DIALYSIS, 2006, 10 (02) :168-174
[7]   Effects of recombinant human hepatocyte growth factor on the proliferation and function of porcine hepatocytes [J].
Eguchi, S ;
Kawazoe, Y ;
Sugiyawa, N ;
Kawashita, Y ;
Fujioka, H ;
Furui, J ;
Sato, M ;
Ishii, T ;
Kanematsu, T .
ASAIO JOURNAL, 2000, 46 (01) :56-59
[8]   Liver transplantation for fulminant hepatic failure - Experience with more than 200 patients over a 17-year period [J].
Farmer, DG ;
Anselmo, DM ;
Ghobrial, RM ;
Yersiz, H ;
McDiarmid, SV ;
Cao, C ;
Weaver, M ;
Figueroa, J ;
Khan, K ;
Vargas, J ;
Saab, S ;
Han, S ;
Durazo, F ;
Goldstein, L ;
Holt, C ;
Busuttil, RW .
ANNALS OF SURGERY, 2003, 237 (05) :666-675
[9]   Hepatocyte transplantation: State of the art [J].
Ferreira Galvao, Flavio Henrique ;
de Andrade Junior, Dahir Ramos ;
de Andrade, Dahir Ramos ;
Martins, Bruno Costa ;
Marson, Allan Garms ;
Bernard, Christiano Vinicius ;
dos Santos, Sania Alves ;
Bacchella, Telesforo ;
Cesar Machado, Marcel Cerqueira .
HEPATOLOGY RESEARCH, 2006, 36 (04) :237-247
[10]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF A PATIENT WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
SAKIYAMA, O ;
TAKAHASHI, K ;
MIYAZAKI, H ;
HASHIMOTO, S ;
DAIKUHARA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :414-419